Cargando…
Prospective evaluation of the clinical utility of endoscopic submucosal dissection (ESD) in patients with Barrett’s esophagus: a Western center experience
Background and study aims: Endoscopic submucosal dissection (ESD) carries significant advantages over endoscopic mucosal resection. As such, ESD is an established therapy for esophageal squamous cell carcinoma but there are only limited data on ESD as therapy for Barrett’s esophagus (BE). Thus, we p...
Autores principales: | Coman, Roxana M., Gotoda, Takuji, Forsmark, Christopher E., Draganov, Peter V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
© Georg Thieme Verlag KG
2016
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993890/ https://www.ncbi.nlm.nih.gov/pubmed/27556083 http://dx.doi.org/10.1055/s-0042-101788 |
Ejemplares similares
-
Endoscopic submucosal dissection (ESD) for Barrett’s esophagus (BE)-related early neoplasia after standard endoscopic management is feasible and safe
por: Tomizawa, Yutaka, et al.
Publicado: (2020) -
Barrett's esophagus: The advocacy for ESD
por: Deprez, Pierre H.
Publicado: (2016) -
Wide-field endoscopic submucosal dissection for the treatment of Barrett’s esophagus neoplasia
por: Omae, Masami, et al.
Publicado: (2021) -
Salvage circumferential endoscopic submucosal dissection for refractory dysplastic Barrett’s esophagus
por: Bechara, Robert, et al.
Publicado: (2020) -
Endoscopic Submucosal Dissection (ESD) in Colorectal Tumors
por: Dumoulin, Franz Ludwig, et al.
Publicado: (2014)